Susquehanna International Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,550
Closed -$15K 12416
2024
Q2
$15K Buy
+2,550
New +$20.2K ﹤0.01% 11716
2022
Q4
Sell
-2,780
Closed -$37K 12938
2022
Q3
$37K Buy
2,780
+160
+6% +$2.46K ﹤0.01% 12365
2022
Q2
$43K Sell
2,620
-3,380
-56% -$56K ﹤0.01% 12054
2022
Q1
$137K Buy
+6,000
New +$108K ﹤0.01% 11634
2021
Q4
Sell
-4,980
Closed -$293K 13436
2021
Q3
$293K Sell
4,980
-2,730
-35% -$198K ﹤0.01% 10657
2021
Q2
$706K Buy
7,710
+4,700
+156% +$627K ﹤0.01% 8723
2021
Q1
$405K Sell
3,010
-4,720
-61% -$569K ﹤0.01% 9957
2020
Q4
$857K Buy
7,730
+5,520
+250% +$596K ﹤0.01% 7068
2020
Q3
$209K Buy
+2,210
New +$225K ﹤0.01% 9376

Other funds holding HOOK

Susquehanna International Group's HOOK Position: Q3 2025 in Review

Susquehanna International Group sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 37,265 shares — an estimated $46.8K sold.

Susquehanna International Group first reported a position in HOOK in Q3 2020 and held it in 13 quarters. The position peaked at $609K in Q2 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Susquehanna International Group reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 37,265 HOOKIPA Pharma shares in Q3 2025, an estimated $46.8K.
  • Susquehanna International Group first reported a position in HOOKIPA Pharma in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's HOOKIPA Pharma position peaked at $609K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.